Enem Nostrum Remedies Private Limited, a active private limited company, was established on 01 January 2001 in Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24229MH2001PTC130260. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.35 Cr and a paid-up capital of ₹2.35 Cr.
It upholds a compliant status. Employing 143 professional, Its leadership includes Anilkumar Shridhar Mulye (Director), Shraddha Vinayak Dhamankar (Director). Past directors included Jayant Hari Ranade, Prashant Raghunandan Rele, Nirmal Vasant Mulye. It holds ₹40.14 Cr open charges and ₹104.69 Cr settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at 201-204, Gayatri Commercial Complex, Behind Mittal Ind.Estate, Kurla-Andheri Road, Andheri, (E),, Mumbai, Maharashtra, 400059.
U24229MH2001PTC130260
130260
01 January 2001
₹4.35 Cr
₹2.35 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Enem Nostrum Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anilkumar Shridhar Mulye | Director | 16 Sep 2024 | Current |
| Shraddha Vinayak Dhamankar | Director | 01 Jan 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Sep 2024 | Past |
| Pramod Abcsdd | Director | 05 Jan 2010 | Past |
| Pramod Abcsdd | Director | 21 Apr 2025 | Past |
| Pramod Abcsdd | Director | 07 Jul 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2024 | Past |
| Pramod Abcsdd | Director | 30 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enem Nostrum Remedies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.28% increase. The company also saw a substantial fall in profitability, with a 38.48% decrease in profit. The company's net worth moved up by a moderate rise of 1.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Enem Nostrum Remedies had a promoter holding of 99.99%. The company had 6 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹401,439,600.00
₹1,046,857,680.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2022 | Bank Of India | ₹37.11 Cr | Open |
| 04 Mar 2022 | Others | ₹4.77 M | Open |
| 14 Feb 2014 | Biotechnology Industry Research Assistance Council | ₹2.56 Cr | Open |
| 11 Mar 2022 | Others | ₹4.77 M | Satisfied |
| 16 Dec 2021 | Hdfc Bank Limited | ₹21.89 Cr | Satisfied |
Explore comprehensive loan charge details -
Enem Nostrum Remedies has a workforce of 143 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Enem Nostrum Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enem Nostrum Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 11 Mar 2022 via Charge ID 100562502 with Others was fully satisfied on 06 May 2025. was completed.
Progress on Enem Nostrum Remedies Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was documented.
The activity Anilkumar Shridhar Mulye was appointed as a Director was appointed as a Director on 16 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Enem Nostrum Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Bank Of India of Rs. 37.11 Cr registered on 05 Dec 2022 with Charge ID 100666599 was modified on 11 Jul 2023. was documented.
Progress on A charge registered on 16 Dec 2021 via Charge ID 100514737 with Hdfc Bank Limited was fully satisfied on 21 Dec 2022. was documented.
The CIN of Enem Nostrum Remedies Private Limited is U24229MH2001PTC130260.
Enem Nostrum Remedies Private Limited is headquartered at 201-204, Gayatri Commercial Complex, Behind Mittal Ind.Estate, Kurla-Andheri Road, Andheri, (E),, Mumbai, Maharashtra, 400059.
Enem Nostrum Remedies Private Limited was incorporated on 01 January 2001.
The current directors of Enem Nostrum Remedies Private Limited are
The primary industry of Enem Nostrum Remedies Private Limited is Professional, Scientific And Technical.
Enem Nostrum Remedies Private Limited is unlisted.
The authorized capital of Enem Nostrum Remedies Private Limited is ₹4.35 Cr, and the paid-up capital is ₹2.35 Cr.
The compliance status of Enem Nostrum Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX